Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Dyslipidemia

  Free Subscription


Articles published in Curr Opin Lipidol

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    October 2020
  1. YEANG C, Willeit P, Tsimikas S
    The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia.
    Curr Opin Lipidol. 2020 Oct 6. doi: 10.1097/MOL.0000000000000713.
    PubMed     Abstract available


  2. IBRAHIM S, Reeskamp LF, Stroes ESG, Watts GF, et al
    Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods.
    Curr Opin Lipidol. 2020 Oct 6. doi: 10.1097/MOL.0000000000000714.
    PubMed     Abstract available


    September 2020
  3. WOLSKA A, Yang ZH, Remaley AT
    Hypertriglyceridemia: new approaches in management and treatment.
    Curr Opin Lipidol. 2020 Sep 29. doi: 10.1097/MOL.0000000000000710.
    PubMed     Abstract available


    June 2020
  4. SORAN H, Cooper JA, Durrington PN, Capps N, et al
    Non-HDL or LDL cholesterol in heterozygous familial hypercholesterolaemia: findings of the Simon Broome Register.
    Curr Opin Lipidol. 2020 Jun 28. doi: 10.1097/MOL.0000000000000692.
    PubMed     Abstract available


  5. BELANGER AM, Akioyamen L, Alothman L, Genest J, et al
    Evidence for improved survival with treatment of homozygous familial hypercholesterolemia.
    Curr Opin Lipidol. 2020 Jun 8. doi: 10.1097/MOL.0000000000000686.
    PubMed     Abstract available


    April 2020
  6. BRANDTS J, Dharmayat KI, Ray KK, Vallejo-Vaz AJ, et al
    Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Curr Opin Lipidol. 2020 Apr 22. doi: 10.1097/MOL.0000000000000675.
    PubMed     Abstract available


  7. BAJAJ A, Cuchel M
    Homozygous familial hypercholesterolemia: what treatments are on the horizon?
    Curr Opin Lipidol. 2020 Apr 22. doi: 10.1097/MOL.0000000000000677.
    PubMed     Abstract available


    January 2020
  8. D'ERASMO L, Di Costanzo A, Arca M
    Autosomal recessive hypercholesterolemia: update for 2020.
    Curr Opin Lipidol. 2020 Jan 31. doi: 10.1097/MOL.0000000000000664.
    PubMed     Abstract available


    December 2019
  9. HOLVEN KB, Ulven SM, Bogsrud MP
    Editorial Comment: Hyperlipidaemia and cardiovascular disease and impact of early cholesterol accumulation.
    Curr Opin Lipidol. 2019;30:490-493.
    PubMed    


    August 2019
  10. TADA H, Nohara A, Kawashiri MA
    Monogenic, polygenic, and oligogenic familial hypercholesterolemia.
    Curr Opin Lipidol. 2019;30:300-306.
    PubMed     Abstract available


    June 2019
  11. SORAN H, Ho JH, Adam S, Durrington PN, et al
    Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia.
    Curr Opin Lipidol. 2019 Jun 18. doi: 10.1097/MOL.0000000000000614.
    PubMed     Abstract available


  12. BURKHARDT R
    Hyperlipidemia and cardiovascular disease: new insights on lipoprotein(a).
    Curr Opin Lipidol. 2019;30:260-261.
    PubMed    


    May 2019
  13. HUET F, Roubille C, Roubille F
    Is hypertriglyceridemia atherogenic?
    Curr Opin Lipidol. 2019 May 27. doi: 10.1097/MOL.0000000000000622.
    PubMed     Abstract available


    April 2019
  14. ALVES AC, Chora JR, Bourbon M
    Genomics of familial hypercholesterolaemia.
    Curr Opin Lipidol. 2019;30:148-150.
    PubMed    


    February 2019
  15. PEREZ-MATOS MC, Sandhu B, Bonder A, Jiang ZG, et al
    Lipoprotein metabolism in liver diseases.
    Curr Opin Lipidol. 2019;30:30-36.
    PubMed     Abstract available


    January 2019
  16. AWAN ZA, Bondagji NS, Bamimore MA
    Recently reported familial hypercholesterolemia-related mutations from cases in the Middle East and North Africa region.
    Curr Opin Lipidol. 2019 Jan 28. doi: 10.1097/MOL.0000000000000586.
    PubMed     Abstract available


  17. MINAME MH, Bittencourt MS, Nasir K, Santos RD, et al
    Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Curr Opin Lipidol. 2019 Jan 14. doi: 10.1097/MOL.0000000000000573.
    PubMed     Abstract available


  18. TOMLINSON B, Hu M, Chow E
    Current status of familial hypercholesterolemia in Chinese populations.
    Curr Opin Lipidol. 2019 Jan 14. doi: 10.1097/MOL.0000000000000580.
    PubMed     Abstract available


    June 2018
  19. TIETGE UJF
    PURE and simple? A new perspective on the impact of diet on hyperlipidemia and cardiovascular risk.
    Curr Opin Lipidol. 2018;29:273-274.
    PubMed    


    April 2018
  20. PAQUETTE M, Baass A
    Predicting cardiovascular disease in familial hypercholesterolemia.
    Curr Opin Lipidol. 2018 Apr 26. doi: 10.1097/MOL.0000000000000519.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: